Schulman S
Department of Medicine, Coagulation Unit, Division of Hematology, Karolinska Hospital, Stockholm, Sweden.
J Intern Med. 2003 Oct;254(4):308-12. doi: 10.1046/j.1365-2796.2003.01223.x.
In this Minisymposium three principles for anticoagulant therapy are discussed and examples of novel, selective coagulation inhibitors at the stage of advanced clinical trials are given. This introduction attempts to explain the different mechanisms of action on a broad scale, and also includes a brief look at effects on inflammation and cancer.
在本次小型研讨会上，讨论了抗凝治疗的三项原则，并给出了处于晚期临床试验阶段的新型选择性凝血抑制剂的实例。本引言试图从广义上解释不同的作用机制，还简要探讨了其对炎症和癌症的影响。
